Details for New Drug Application (NDA): 217598
✉ Email this page to a colleague
The generic ingredient in LORAZEPAM is lorazepam. There are eleven drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
Summary for 217598
| Tradename: | LORAZEPAM |
| Applicant: | Fresenius Kabi Usa |
| Ingredient: | lorazepam |
| Patents: | 0 |
Suppliers and Packaging for NDA: 217598
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LORAZEPAM | lorazepam | INJECTABLE;INJECTION | 217598 | ANDA | Fresenius Kabi USA, LLC | 65219-368 | 65219-368-02 | 25 VIAL in 1 TRAY (65219-368-02) / 1 mL in 1 VIAL (65219-368-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML | ||||
| Approval Date: | Nov 18, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
